Daniel W. Beury

发表

Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2

P. Sinha, S. Ostrand-Rosenberg, N. Wali, 2016, The Journal of Immunology.

Chapter 28 – Tumor-induced Myeloid-derived Suppressor Cells

P. Sinha, S. Ostrand-Rosenberg, Olesya Chornoguz, 2013 .

Cross‐talk among myeloid‐derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors

P. Sinha, S. Ostrand-Rosenberg, Kayla A. Carter, 2014, Journal of leukocyte biology.

Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.

P. Sinha, S. Ostrand-Rosenberg, Daniel W. Beury, 2012, Seminars in cancer biology.

Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment

S. Ostrand-Rosenberg, Daniel W. Beury, K. Parker, 2019, Cancer Immunology, Immunotherapy.

Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas

S. Steinberg, R. Kaplan, B. Widemann, 2020, Clinical Cancer Research.

Reversing Breast Cancer-Induced Immune Suppression

S. Ostrand-Rosenberg, Daniel W. Beury, 2014 .

IDO is a nodal pathogenic driver of lung cancer and metastasis development.

G. Prendergast, A. P. Soler, R. Metz, 2012, Cancer discovery.

Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis

S. Hannenhalli, R. Kaplan, J. Drake, 2021, Cell.

KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis

R. Kaplan, M. Kruhlak, G. Owens, 2017, Nature Medicine.

Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

S. Ostrand-Rosenberg, Daniel W. Beury, K. Parker, 2015, Advances in cancer research.